Home
About
Overview
Sharing Data
ORCID
Help
History (26)
Radiomic prediction of mutation status based on MR imaging of lung cancer brain metastases.
Pathologic Considerations and Standardization in Mesothelioma Clinical Trials.
The promise of selective MET inhibitors in non-small cell lung cancer with MET exon 14 skipping.
Osimertinib long-term tolerability in patients with EGFRm NSCLC enrolled in the AURA program or FLAURA study.
Afatinib in the treatment of squamous non-small cell lung cancer: a new frontier or an old mistake?
See All 26 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Afatinib in the treatment of squamous non-small cell lung cancer: a new frontier or an old mistake?
Afatinib in the treatment of squamous non-small cell lung cancer: a new frontier or an old mistake? Transl Lung Cancer Res. 2016 Feb; 5(1):110-4.
View in:
PubMed
authors with profiles
Marina Chiara Garassino